As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

President Trump has eliminated funding for programs aimed at ending the growing HIV epidemic among minority communities, ...

Funding cuts have shaken every state, but the South is acutely vulnerable when it comes to HIV, said Gregorio Millett, MPH, ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

It used to be that Chinese drug development was largely about creating "me too" drugs for the local market. But over the past ...